Is fecal calprotectin the next standard in inflammatory bowel disease activity tests?

被引：2

作者：

Alic, M

机构：

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 1999年 / 94卷 / 11期

关键词：

D O I：

10.1111/j.1572-0241.1999.03370.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：3370 / 3371

页数：2

共 10 条

[1]

Bunn SK, 1999, GUT, V44, pA35

[2] Fecal marker variability in colorectal cancer: Calprotectin versus hemoglobin [J].

Gilbert, JA ;

Ahlquist, DA ;

Mahoney, DW ;

Zinsmeister, AR ;

Rubin, J ;

Ellefson, RD .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1996, 31 (10) :1001-1005

[3]

Johne B, 1997, J CLIN PATHOL-MOL PA, V50, P113

[4]

LIMBURG P, 1998, ACG ANN M OCT BOST M

[5]

Pimentel M, 1999, GASTROENTEROLOGY, V116, pA796

[6]

Roseth AG, 1999, SCAND J GASTROENTERO, V34, P50

[7] Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein [J].

Roseth, AG ;

Aadland, E ;

Jahnsen, J ;

Raknerud, N .

DIGESTION, 1997, 58 (02) :176-180

[8] ASSESSMENT OF THE NEUTROPHIL DOMINATING PROTEIN CALPROTECTIN IN FECES - A METHODOLOGIC STUDY [J].

ROSETH, AG ;

FAGERHOL, MK ;

AADLAND, E ;

SCHJONSBY, H .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1992, 27 (09) :793-798

[9]

Schmidt PN, 1999, GASTROENTEROLOGY, V116, pA814

[10]

Tibble JA, 1999, GUT, V44, pA35

← 1 →